E4	Observation:T4 Name:T5 Eq-Comparison:E16 Eq-Comparison2:E17
E7	Procedure:T7 Temporality:E26 Name:T8
E9	Procedure:T9 Name:T10 Temporality:E29
E10	Age:T23 Eq-Comparison:E13
E11	Age:T24 Eq-Comparison:E14
E12	Age:T25 Eq-Comparison:E18
E13	Eq-Comparison:T32 Operator:T11 Temporal-Unit:T18 Value:T26
E14	Eq-Comparison:T33 Operator:T12 Temporal-Unit:T19 Value:T27
E15	Eq-Comparison:T34 Operator:T14 Temporal-Unit:T20 Value:T28
E16	Eq-Comparison:T35 Operator:T15 Value:T29
E17	Eq-Comparison:T36 Operator:T16 Value:T30 Per:T71 Unit:T22
E18	Eq-Comparison:T37 Operator:T17 Temporal-Unit:T21 Value:T31
E2	Or:T41 Arg:E10 Arg2:E11
E3	Encounter:T43 Type:T44 Temporality:E5
E5	Eq-Comparison:T45 Temporal-Period:T46
E6	Observation:T47 Name:T48
E1	Study:T1
E8	And:T2 Arg:E6 Arg2:E1
E20	Assertion:T49 Asserted:E3
E21	Assertion:T50 Asserted:E3
E22	And:T51 Arg:E20 Arg2:E21
E23	Condition:T52 Name:T53
E25	Condition:T55 Name:T56
E26	Eq-Comparison:T57 Temporal-Period:T58
E27	Or:T59 Arg:E7 Arg2:E25
E28	Modifier:T60 Modifies:T10
E24	Drug:T54 Name:T61
E29	Eq-Comparison:T62 Temporal-Period:T63
E30	And:T64 Arg:E9 Arg2:E32
E31	Drug:T65 Name:T66
E32	Procedure:T67 Temporality:E29
E33	Condition:T13 Name:T69 Duration:E15
E34	Or:T70 Arg:E16 Arg2:E17
E35	Or:T73 Arg:T6 Arg2:T72
E36	Condition:T74
E37	Modifier:T75 Modifies:E36
E38	Modifier:T76 Modifies:E36
E39	Modifier:T77 Modifies:E36
E40	Or:T78 Arg:E38 Arg2:E37
E41	Study:T79 Stability:T80
E42	Condition:T83 Name:T84
E43	And:T85 Arg:T82 Arg2:T81
E44	Family-Member:T86
E45	And:T87 Arg:T81 Arg2:E44
E19	Condition:T38 Name:T39
T3	Life-Stage-And-Gender 220 225	child
T4	Observation 677 692	Body mass index
T5	Observation-Name 677 692	Body mass index
T6	Life-Stage-And-Gender 722 727	Child
T7	Procedure 477 490	ART treatment
T9	Procedure 529 532	ART
T10	Procedure-Name 529 532	ART
T11	Eq-Operator 231 232	≥
T12	Eq-Operator 263 264	≥
T14	Eq-Operator 656 657	>
T15	Eq-Operator 693 694	>
T16	Eq-Operator 700 701	<
T17	Eq-Operator 747 748	<
T18	Eq-Temporal-Unit 234 239	years
T19	Eq-Temporal-Unit 266 271	years
T20	Eq-Temporal-Unit 660 665	weeks
T21	Eq-Temporal-Unit 751 756	years
T22	Eq-Unit 706 708	Kg
T23	Age 226 230	aged
T24	Age 258 262	aged
T25	Age 742 746	aged
T26	Eq-Value 232 233	7
T27	Eq-Value 264 265	8
T28	Eq-Value 657 659	20
T29	Eq-Value 694 696	30
T30	Eq-Value 701 705	18.5
T31	Eq-Value 748 750	18
T32	Eq-Comparison 231 239	≥7 years
T33	Eq-Comparison 263 271	≥8 years
T34	Eq-Comparison 656 665	>20 weeks
T35	Eq-Comparison 693 696	>30
T36	Eq-Comparison 700 711	<18.5 Kg/m2
T37	Eq-Comparison 747 756	<18 years
T40	Location 241 253	South Africa
T41	Or 255 257	or
T42	Location 273 279	Uganda
T43	Encounter 384 390	visits
T44	Encounter-Type 384 390	visits
T45	Eq-Comparison 374 383	scheduled
T46	Eq-Temporal-Period 374 383	scheduled
T47	Observation 392 408	laboratory tests
T48	Observation-Name 392 408	laboratory tests
T1	Study 420 425	study
T2	And 410 413	and
T49	Assertion 342 349	willing
T50	Assertion 354 358	able
T51	And 350 353	and
T52	Condition 443 455	HIV-infected
T53	Condition-Name 443 455	HIV-infected
T55	Condition 494 506	HIV-infected
T56	Condition-Name 494 506	HIV-infected
T57	Eq-Comparison 457 466	receiving
T58	Eq-Temporal-Period 457 466	receiving
T59	Or 491 493	OR
T60	Modifier 517 528	second-line
T54	Drug 467 470	ATV
T61	Drug-Name 467 470	ATV
T62	Eq-Comparison 507 516	receiving
T63	Eq-Temporal-Period 507 516	receiving
T64	And 533 537	with
T65	Drug 549 558	rifamycin
T66	Drug-Name 549 558	rifamycin
T67	Procedure 568 577	treatment
T13	Condition 646 654	Pregnant
T69	Condition-Name 646 654	Pregnant
T70	Or 697 699	or
T71	Eq-Unit 709 711	m2
T72	Life-Stage-And-Gender 731 741	adolescent
T73	Or 728 730	or
T74	Condition 816 825	condition
T75	Modifier 806 815	obstetric
T76	Modifier 791 802	psychiatric
T77	Modifier 782 789	Medical
T78	Or 803 805	or
T79	Study 865 869	stuy
T80	Stability 837 843	affect
T81	Location 955 961	Uganda
T82	Life-Stage-And-Gender 946 951	women
T83	Condition 937 945	pregnant
T84	Condition-Name 937 945	pregnant
T85	And 952 954	in
T86	Family-Member 973 980	husband
T87	And 963 968	where
T38	Condition 565 567	TB
T39	Condition-Name 565 567	TB
T8	Procedure-Name 477 490	ART treatment
A1	Life-Stage-And-Gender-Type T3 child
A2	Observation-Type-Value T5 vital
A3	Life-Stage-And-Gender-Type T6 child
A4	Eq-Operator-Value T11 GTEQ
A5	Eq-Operator-Value T12 GTEQ
A7	Eq-Operator-Value T14 GT
A8	Eq-Operator-Value T15 GT
A9	Eq-Operator-Value T16 LT
A10	Eq-Operator-Value T17 LT
A11	Eq-Temporal-Unit-Value T18 year
A12	Eq-Temporal-Unit-Value T19 year
A13	Eq-Temporal-Unit-Value T20 week
A14	Eq-Temporal-Unit-Value T21 year
A16	Location-Value T40 residence
A17	Location-Value T42 residence
A18	Encounter-Type-Value T44 outpatient
A19	Eq-Temporal-Period-Value T46 future
A20	Observation-Type-Value T48 lab
A21	Assertion-Type-Value E20 hypothetical
A22	Assertion-Type-Value E21 hypothetical
A23	Eq-Temporal-Period-Value T58 present
A24	Eq-Temporal-Period-Value T63 present
A6	Life-Stage-And-Gender-Type T72 child
A25	Stability-Value T80 change
A26	Location-Value T81 residence
A27	Life-Stage-And-Gender-Type T82 female
A28	Family-Member-Type E44 spouse
R1	If-Then Arg1:T40 Arg2:E10
R2	If-Then Arg1:T42 Arg2:E11
R3	Using Arg1:E7 Arg2:E24
R4	Using Arg1:E32 Arg2:E31
R5	Caused-By Arg1:T80 Arg2:E36
R6	If-Then Arg1:T82 Arg2:E42
R7	Treatment-For Arg1:E32 Arg2:E19